Top Banner
Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader
39

Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Dec 14, 2015

Download

Documents

Hannah Guyon
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Linking Drug Stability to ManufacturingPhysical Chemical Foundations

Gabapentin

L. E. KirschStability team leader

Page 2: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Stability TeamGroup Team member

Minnesota Raj Suryanarayanan (Co-PI)

Aditya Kaushal (post-doc)

Kansas Eric Munson (Co-PI)

Dewey Barich (post-doc)

Elodie Dempah, Eric Gorman (grad. students)

Iowa Lee Kirsch (Co-PI)

Greg Huang (Analytical Chemist)

Salil Desai, Zhixin Zong, Tinmanee Radaduen, Hoa Nguyen, Jiang Qiu (grad students)

Duquesne(Unit-op team Interface)

Ira Buckner

Page 3: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Linking manufacturing to stability

3

(Stable form)

(Unstable form)

Page 4: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Gabapentin as a model drug substance

NH2

OH

O

gabapentin(Gaba)

• Multiple crystalline forms• Susceptible to stress-induced physical

transformations• Susceptible to chemical degradation

NH3+

O-

O

NH2

O-

O

NH3+

OH

O

pKa 3.7 pKa 10

4

KEY QUESTIONS1. Are physical and chemical instability

linked?2. How can manufacturing-induced stress be

incorporated in a quantitative chemical instability model?

Page 5: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Some Crystalline Forms of Gabapentin

5

API form Crystalline

I

II

III

IV

Ibers., Acta Cryst c57, 2001 and Reece and Levendis., Acta Cryst. c64 2008

Transition between forms by mechanical stress, humidity, and thermal stress

Hydrate

Stable polymorph (API)

Intramolecular H-bonding

Page 6: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

4 6 8 10 12 14 16 18 20 22

2Theta

Physical transformation by Mechanical Stress

Form II

Form III

Milled Gabapentin

Page 7: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Physical transformation by Humidity

2theta

7

Inte

nsity

47 hrs in 40C 31 %RH29 hrs17 hrs 7 hrs 0 hr

Page 8: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Physical transformation by Thermal Stress

Kaushal and Suryanarayanan., Minnesota Univ. AAPS poster 2009

8

Page 9: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Chemical Degradation of Gabapentin– nucleophilic attack of nitrogen on carbonyl

O

NH

Gabapentin Gabapentin _lactam

9

toxicUSP limit: < 0.4%

Page 10: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Aqueous degradation kinetics

OOH

NH2NH

O

gabapentin lactam

Irreversible cyclization

+ H2O

Page 11: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Solid state degradation kinetics40 C 5% RH, milled gabapentin

0

1

2

3

4

5

6

7

0 100 200 300 400 500 600

Lac

tam

(m

ole

%)

hours

initial lactamrapid degradation of process-damaged gaba

autocatalytic lactam formation

Page 12: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Solid state Degradation Model

12

GABA (G)(stable form)

LACTAM (L)

autocatalytic branching

spontaneous dehydration

branching termination

LDGk 1

Dk2GABA (D)(unstable form)

DGk3

Hypothesis:Manufacturing stress determines initial conditions (G0, D0 and L0)Environmental (storage) stress determines kinetics (k1, k2 and k3)

Page 13: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Building a quantitative model

13

DrugStability

Compositional Factors

(e.g. excipients)

Environmental Stress

ManufacturingStress

Page 14: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effects of Manufacturing Stress:Initial Lactam and Instability

0 5 10 15 20 25 300.0

0.5

1.0

1.5

2.0

2.5

% la

ctam

time(days)

60 min milled

45 min milled

15 min milled

API as received

Thermal stressed at 50 °C, 5%RH

Lactam generated during milling(in-process lactam)

Milling caused faster degradation rate

14

Page 15: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effects of Milling Stress:Specific Surface Area

0 20 40 600

4

8

12

16

20

Surf

ace A

rea

(m2 /g

)

Milling Time (min)

Is the increase of lactamization rate solely due to increase of Surface Area?

15

Page 16: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Can Surface Area account for Lactamization Rate Changes upon

Mechanical Stess?

Samples milled for different time

Sieved aliquots of 15min milled sample

Sieved aliquots of unmilled sample

NO, ALSO increased regions of crystal disorder caused by the mechanical stress.

16

Page 17: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effects of Milling based on Change in Initial Condition:

lactam formation (50 °C)

17

TreatmentD0

(%)k1*104

(%mole-1hr-1)

k2(hr-1)

unstressed 0.02

0.6 0.017

15min milled 0.5945min milled 1.2860min milled 1.62

Lact

am m

ole

%

Time (hr)

60min mill

45min mill

15min mill

unstressed0

0.5

1

1.5

2

2.5

3

3.5

0 200 400 600 800 1000 1200 1400

milling time effect

Page 18: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effects of Environmental Stress: temperature and humidity

18

DrugStability

Compositional Factors

(e.g. excipients)

Environmental Stress

ManufacturingStress

Page 19: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Lactam kinetics under controlled temperature (40-60 C) and humidity (5-50% RH)

0

5

10

15

20

0 100 200 300 400 500 600 700 800

Lac

tam

(%

mo

le)

Hours

Page 20: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effects of Temperature:predicted values based on parameterization of

autocatalytic model

Page 21: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effects of Moisture

21

Page 22: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Is the decreased lactam rate due to reversible reaction?

• Thermal stress of solid state (milled) or aqueous gabapentin_lactam– No detectable loss of lactam and no appearance

of gabapentin in solution and solid state

Zong et.al., Draft submitted to AAPS Pharm Sci Tech. 2010

COOHNH2

O

NH

Gabapentin Gabapentin_lactam

+H20

22

Page 23: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Why moisture appears to slow and shut down lactam formation?

• In general, effect of moisture is NOT to slow reaction rates

• Analytical issue?

• Reversible reaction?

• Formation of stable hydrate?

No gabapentin formed from gaba-L in solution or solid state

No hydrate found from XRD patterns

Most gaba-L could be recovered from solid powder, only ignorable gaba-L was detected in saturated salt solution.

Moisture-facilitated termination of branching23

Page 24: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effect of Moisture:Shut down Lactam Formation

0

1

2

3

4

0 20 40 60 80 100

Gaba

-L C

once

ntra

tion

(Mol

e %

)

Hours

Pretreated at 5% RH 25°C for 24 hours before thermal stress

Pretreated at 81% RH 25°C for 24 hours before thermal stress

Thermal stress: 50°C 5%RH

24

Page 25: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

k1 (%mole-1hr-1)

k2 (hr-1)

D0 (%)

L0 (% mole)

0.000021 0.0074 1.05 0.37k3(%mole-1hr-1)

5%RH 11%RH 30%RH 50%RH

�0 0.014 0.030 0.099

Effects of Moisture

40 C 50%RH

40 C 30%RH

40 C 5%RH

25

Lact

am m

ole

%

Time (hr)

40 C 11%RH

0

1

2

3

4

5

0 100 200 300 400 500

moisture effect gaba simulation

Page 26: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effects of Compositional Factors: excipient effects

26

DrugStability

Compositional Factors

(e.g. excipients)

Environmental Stress

ManufacturingStress

Page 27: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Excipient EffectsComparison of lactam formation kinetics between neet gabapentin

and gabapentin/HPCcontrolled temperature (40-60 C) and humidity (5-50% RH)

0

10

20

30

40

50

60

0 100 200 300 400 500 600 700 800

La

cta

m (

%m

ole

)

Hours

Gabapentin

0

10

20

30

40

50

60

0 100 200 300 400 500 600 700 800

La

cta

m (

% m

ole

)

Hours

Gabapentin & 6.5% HPC

Page 28: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

– Mixtures of gabapentin & excipients– Co-milled– Storage conditions: 5 to 50% RH at 50 ˚C

• Excipients (50% w/w)

– CaHPO4.2H20 (Emcompress)

– Corn starch– Microcrystalline cellulose (Avicel PH101)– HPMC 4000

– Colloidal SiO2 (Cab-O-Sil)

– Talc (Mg silicate)– HPC (6.5% w/w)

Evaluation of the role of excipients in gabapentin SS degradation

Saturated solution Saturated solution 50˚C

0

10

20

30

40

50

0 100 200 300 400 500

5RH 4:47:40 AM 10/22/2010

gabaAviHPMCCabTalcHPC Calccorngaba obscalc obscorn obsAvi obsHPMC obsCab obsTalc obsHPC obs

Gaba

Starch

CaHPO4SiO2

HPC AvicelHPMC

Talc

Lact

am m

ole

%Time (hr)

Page 29: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Model parameterization usingexcipient-induced variation in crystal damage during

milling and termination rate

0

10

20

30

40

50

0 100 200 300 400 500

La

cta

m (

% m

ole

)

Hours

SiO2

CaHPO4

Starch

MCC

HPMC

Talc

HPC (6.5%)

Excipient effects•Crystal damage (D0) during milling•Kinetics of branching and termination(k3)

Page 30: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effect of Excipients based on Change in Initial Conditions and Rate Constants:

under low humidity

30

k1 *104

(%mole-1hr-1) k2(hr-1)

D0

(%)L0

(% mole)SiO2 0.27 0.0208 21.16 2.6Talc 0.33 0.0116 8.44 0.98Starch 0.35 0.0150 4.54 0.30HPMC 0.41 0.0123 7.42 0.30Avicel 0.49 0.0148 7.21 0.26

HPC (6.5%) 0.55 0.0209 6.52 0.30Gaba 0.74 0.0149 1.05 0.37

Page 31: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Effect of Excipients based on Change in Rate Constants: under low humidity

31

Page 32: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Moisture and excipient effectsNo excipient Co-milled excipient (SiO2)

5 %RH 11 %RH30 %RH

50 %RH

11 %RH

30 %RH

50 %RH

5 %RH

32

0

10

20

30

40

50

0 100 200 300 400 500 600

Data 10

BDFH

Lact

am m

ole

%

Time (hr)

0

5

10

15

20

0 100 200 300 400 500 600 700 800

moisture effect gaba50RH

0RH11RH30RH50RH

Page 33: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Linking Stability in Design SpaceManuf.Design SpaceModel

L0

D0

Post-Manuf.

Degradation

Model

LtEndof

Expiry

• Key Research Findings• Manufacturing Stress impacts drug stability upon storage:

L0 (in-process lactam) D0 (unstable gabapentin)

• Predictive model for drug stability includes:• Environment factor: temperature () & humidity ()

• Compositional factors: both kinetic and initial condition effects

• Manufacturing factors: L0 and D0

• Model validation: completion of long term stability

Page 34: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Measuring the manufacturing stress effects• Physical methods

– Raj Suryanarayanan (University of Minnesota) – Eric Munson (University of Kentucky)

• Chemical and kinetic measurements– Lee Kirsch (University of Iowa

Solid State NMR KansasRaman spectroscopy MinnesotaPowder x-ray diffraction (XRD) MinnesotaDSC/TGA All Water vapor sorption MinnesotaHPLC Iowa

Page 35: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Chromatographic methods

Minutes

1 2 3 4 5 6 7 8 9 10

mAU

0.00

0.25

0.50

0.75

1.00

1.25

1.50

mAU

0.00

0.25

0.50

0.75

1.00

1.25

1.50

4093

741

Ga

bape

ntin

3.6

58

2388

5.390 43

39

Lacta

m

7.288

3853

9.117

Detector 1-210nmhydBt0H

AreaNameRetention Time

Detector 1-210nmhydBt24H

Comparison of HPLC chromatograms before (black) and after (red) thermal stress:

∆ lactam = 0.004%.

Minutes

1 2 3 4 5 6 7 8 9 10

mAU

0

1

2

3

4

mAU

0

1

2

3

4

2801

635

Ga

bape

ntin

3.6

68

8278

La

ctam

7.3

07

Detector 1-210nmhydAt0H

AreaNameRetention Time

Detector 1-210nmhydAt24H

Comparison of HPLC chromatograms before (black) and after (red) thermal stress:

∆ lactam = 0.059%.

Minutes

1 2 3 4 5 6 7 8 9 10

mAU

0

5

10

15

20

mAU

0

5

10

15

20

4635

741

Ga

bape

ntin

3.618

2878

43

7.5

72

(La

ctam)

Detector 1-210nmlotAH

AreaNameRetention Time

Detector 1-210nmlotAHbefore

Comparison of HPLC chromatograms before (black) and after (red) thermal stress:

∆ lactam = 0.174%.

Page 36: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Manufacturing-stability measurements

• In process lactam (L0)– Change in lactam levels during specific treatment or unit operation in

% lactam/gabapentin on molar basis

• Initial Rate of Lactam Formation (V0 or STS)– Daily rate of lactam formation upon thermal stress at 50°C under low

humidity

• D0 from Chemical Analysis

dayCk

k

VD

DkV

o %/37.0)50(2

2

00

020

Page 37: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Insert Sury

Page 38: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Insert Eric

Page 39: Linking Drug Stability to Manufacturing Physical Chemical Foundations Gabapentin L. E. Kirsch Stability team leader.

Applied Manufacturing-stability Measurements to Design Space and Risk Assessment

• Laboratory scale stability design space• Pilot scale stability design space• Risk assessment using Manufacturing-

stability Measurements